{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:06:12Z","timestamp":1791835572997,"version":"4.3.4"},"reference-count":217,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cyto.2020.155258","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T06:12:53Z","timestamp":1599631973000},"page":"155258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Interleukin-15 in autoimmunity"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7850-2658","authenticated-orcid":false,"given":"Hugues","family":"Allard-Chamard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuparna","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Mayhue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7563-576X","authenticated-orcid":false,"given":"Subburaj","family":"Ilangumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheela","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155258_b0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nature Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028449","article-title":"The common cytokine receptor gamma chain family of cytokines","volume":"10","author":"Lin","year":"2018","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"10.1016\/j.cyto.2020.155258_b0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1074-7613(00)80246-0","article-title":"IL-15: a pleiotropic cytokine with diverse receptor\/signaling pathways whose expression is controlled at multiple levels","volume":"4","author":"Tagaya","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.imlet.2009.09.009","article-title":"Trans-presentation: a novel mechanism regulating IL-15 delivery and responses","volume":"127","author":"Stonier","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2020.155258_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","article-title":"The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens","volume":"17","author":"Waldmann","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells","volume":"38","author":"Fuchs","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0040","doi-asserted-by":"crossref","first-page":"14601","DOI":"10.1038\/ncomms14601","article-title":"IL-15 sustains IL-7R-independent ILC2 and ILC3 development","volume":"8","author":"Robinette","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2020.155258_b0045","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.4049\/jimmunol.176.10.6180","article-title":"MyD88-dependent signaling for IL-15 production plays an important role in maintenance of CD8 alpha alpha TCR alpha beta and TCR gamma delta intestinal intraepithelial lymphocytes","volume":"176","author":"Yu","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1074-7613(02)00429-6","article-title":"IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells","volume":"17","author":"Dubois","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0065","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.biocel.2005.02.017","article-title":"The roles of interleukin-15 receptor alpha: trans-presentation, receptor component, or both?","volume":"37","author":"Schluns","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cyto.2020.155258_b0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cyto.2012.06.017","article-title":"Regulating the immune system via IL-15 transpresentation","volume":"59","author":"Castillo","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2020.155258_b0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2017.08.002","article-title":"Immunobiology of the IL-15\/IL-15Ralpha complex as an antitumor and antiviral agent","volume":"38","author":"Guo","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2020.155258_b0080","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/j.1460-2075.1994.tb06576.x","article-title":"Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15","volume":"13","author":"Giri","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.cyto.2020.155258_b0085","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/jidsymp.2013.8","article-title":"The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders","volume":"16","author":"Waldmann","year":"2013","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.cyto.2020.155258_b0090","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.1002188","article-title":"Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis","volume":"185","author":"Saikali","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jneuroim.2008.01.016","article-title":"Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS","volume":"195","author":"Vaknin-Dembinsky","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cyto.2020.155258_b0100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nri3919","article-title":"IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction","volume":"15","author":"Jabri","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0105","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.200363097","article-title":"IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice","volume":"97","author":"Marks-Konczalik","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0110","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1007\/s00125-012-2675-1","article-title":"Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse","volume":"55","author":"Bobbala","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.cyto.2020.155258_b0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cytogfr.2013.05.004","article-title":"The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response","volume":"24","author":"Pagliari","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2020.155258_b0120","doi-asserted-by":"crossref","first-page":"15849","DOI":"10.1073\/pnas.0908834106","article-title":"Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes","volume":"106","author":"Yokoyama","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm0297-189","article-title":"Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis","volume":"3","author":"McInnes","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/ar1202","article-title":"Targeting the interleukin-15\/interleukin-15 receptor system in inflammatory autoimmune diseases","volume":"6","author":"Waldmann","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2020.155258_b0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","article-title":"Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease","volume":"55","author":"Di Sabatino","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2020.155258_b0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0145","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/sj.jid.5700896","article-title":"Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population","volume":"127","author":"Zhang","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2020.155258_b0150","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s00125-005-1839-7","article-title":"Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets","volume":"48","author":"Ylipaasto","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.cyto.2020.155258_b0155","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.2337\/db11-1547","article-title":"Cytokine and chemokine production by human pancreatic islets upon enterovirus infection","volume":"61","author":"Schulte","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2020.155258_b0160","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.3747\/co.26.4151","article-title":"Diabetes mellitus secondary to treatment with immune checkpoint inhibitors","volume":"26","author":"Venetsanaki","year":"2019","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.cyto.2020.155258_b0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.cyto.2020.155258_b0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/iji.12065","article-title":"Relation of IL-6, IL-13 and IL-15 gene polymorphisms to the rheumatoid factors, anti-CCP and other measures of rheumatoid arthritis activity","volume":"41","author":"Pavkova Goldbergova","year":"2014","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.cyto.2020.155258_b0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cyto.2017.07.009","article-title":"Association of the IL-15 and IL-15Ralpha genes with celiac disease","volume":"99","author":"Escudero-Hernandez","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2020.155258_b0180","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.8178155","article-title":"Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor","volume":"264","author":"Grabstein","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cyto.2020.155258_b0185","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1073\/pnas.91.11.4935","article-title":"A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells","volume":"91","author":"Burton","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0190","doi-asserted-by":"crossref","first-page":"14444","DOI":"10.1073\/pnas.94.26.14444","article-title":"Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides","volume":"94","author":"Tagaya","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0195","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.4049\/jimmunol.160.9.4418","article-title":"The 5' untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control","volume":"160","author":"Bamford","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0888-7543(95)80013-C","article-title":"Chromosomal assignment and genomic structure of Il15","volume":"25","author":"Anderson","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.cyto.2020.155258_b0205","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1074\/jbc.M705725200","article-title":"Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity","volume":"283","author":"Bergamaschi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2020.155258_b0210","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4049\/jimmunol.160.2.936","article-title":"Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA","volume":"160","author":"Nishimura","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0215","first-page":"2187","article-title":"Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines","volume":"12","author":"Meazza","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2020.155258_b0220","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4049\/jimmunol.158.1.255","article-title":"Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms","volume":"158","author":"Onu","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0225","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/eji.1830270502","article-title":"Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides","volume":"27","author":"Meazza","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0230","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1073\/pnas.93.7.2897","article-title":"Interleukin (IL) 15\/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region \/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation","volume":"93","author":"Bamford","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0235","doi-asserted-by":"crossref","first-page":"30653","DOI":"10.1074\/jbc.M002373200","article-title":"The long signal peptide isoform and its alternative processing direct the intracellular trafficking of interleukin-15","volume":"275","author":"Kurys","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2020.155258_b0240","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.4049\/jimmunol.1103609","article-title":"Cutting edge: the role of IFN-alpha receptor and MyD88 signaling in induction of IL-15 expression in vivo","volume":"188","author":"Colpitts","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0245","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.1318281111","article-title":"Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo","volume":"111","author":"Cui","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0250","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4049\/jimmunol.1203149","article-title":"CD8alpha+ dendritic cell trans presentation of IL-15 to naive CD8+ T cells produces antigen-inexperienced T cells in the periphery with memory phenotype and function","volume":"190","author":"Sosinowski","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0255","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2003-01-0175","article-title":"Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes","volume":"102","author":"Ilangumaran","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b0260","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.4049\/jimmunol.176.7.4029","article-title":"Suppressor of cytokine signaling 1 stringently regulates distinct functions of IL-7 and IL-15 in vivo during T lymphocyte development and homeostasis","volume":"176","author":"Ramanathan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0265","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4049\/jimmunol.1100270","article-title":"IL-15Ralpha of radiation-resistant cells is necessary and sufficient for thymic invariant NKT cell survival and functional maturation","volume":"187","author":"Chang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0270","article-title":"Intestinal epithelial cell-derived IL-15 determines local maintenance and maturation of intraepithelial lymphocytes in the intestine","author":"Zhu","year":"2019","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0275","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood-2003-08-2814","article-title":"Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells","volume":"103","author":"Schluns","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b0280","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.0307442101","article-title":"Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression","volume":"101","author":"Schluns","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0285","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.immuni.2009.09.017","article-title":"Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets","volume":"31","author":"Mortier","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cyto.2015.12.012","article-title":"Homeostasis of IL-15 dependent lymphocyte subsets in the liver","volume":"82","author":"Cepero-Donates","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2020.155258_b0295","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1002\/j.1460-2075.1995.tb00035.x","article-title":"Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor","volume":"14","author":"Giri","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.cyto.2020.155258_b0300","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1073\/pnas.91.11.4940","article-title":"The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells","volume":"91","author":"Bamford","year":"1994","journal-title":"Proc. Natl. Acad Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0305","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1182\/blood-2010-09-307504","article-title":"Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Ralpha","volume":"117","author":"Sato","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b0310","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1002\/j.1460-2075.1996.tb00873.x","article-title":"Identification of a novel receptor\/signal transduction pathway for IL-15\/T in mast cells","volume":"15","author":"Tagaya","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.cyto.2020.155258_b0315","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1084\/jem.194.8.1187","article-title":"T cell-independent interleukin 15Ralpha signals are required for bystander proliferation","volume":"194","author":"Lodolce","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0320","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20021836","article-title":"Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice","volume":"197","author":"Koka","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0325","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.4049\/jimmunol.1501638","article-title":"IL-15 complexes induce migration of resting memory CD8 T cells into mucosal tissues","volume":"199","author":"Sowell","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0330","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/MCB.02178-07","article-title":"How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: lessons from interleukin-15 (IL-15)\/IL-15 receptor alpha","volume":"28","author":"Duitman","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cyto.2020.155258_b0335","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.4049\/jimmunol.0900693","article-title":"Secretion and biological activity of short signal peptide IL-15 is chaperoned by IL-15 receptor alpha in vivo","volume":"183","author":"Bergamaschi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0340","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.191.1.157","article-title":"Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo","volume":"191","author":"Nishimura","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1096\/fj.04-2633com","article-title":"A novel autoregulatory mechanism for transcriptional activation of the IL-15 gene by a nonsecretable isoform of IL-15 generated by alternative splicing","volume":"19","author":"Nishimura","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.cyto.2020.155258_b0350","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1084\/jem.20041389","article-title":"Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis","volume":"200","author":"Burkett","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0355","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.4049\/jimmunol.173.11.6537","article-title":"Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells","volume":"173","author":"Sandau","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0360","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2007.03.006","article-title":"Dendritic cells prime natural killer cells by trans-presenting interleukin 15","volume":"26","author":"Lucas","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0365","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20071913","article-title":"IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation","volume":"205","author":"Mortier","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0370","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/ni729","article-title":"Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response","volume":"2","author":"Ohteki","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0375","first-page":"297","article-title":"Different dynamics of IL-15R activation following IL-15 cis- or trans-presentation","volume":"21","author":"Perdreau","year":"2010","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.cyto.2020.155258_b0380","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1073\/pnas.0600240103","article-title":"Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}","volume":"103","author":"Rubinstein","year":"2006","journal-title":"Proc. Natl. Acad Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0385","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.177.9.6072","article-title":"Combined IL-15\/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo","volume":"177","author":"Stoklasek","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0390","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1074\/jbc.M508624200","article-title":"Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta\/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins","volume":"281","author":"Mortier","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2020.155258_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2008.07.019","article-title":"The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha","volume":"382","author":"Bouchaud","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cyto.2020.155258_b0400","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1158\/0008-5472.CAN-12-2357","article-title":"Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor alphaSu\/Fc fusion complex in syngeneic murine models of multiple myeloma","volume":"73","author":"Xu","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2020.155258_b0405","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1158\/1078-0432.CCR-18-0945","article-title":"Phase I trial of ALT-803, a novel recombinant IL15 complex, in patients with advanced solid tumors","volume":"24","author":"Margolin","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2020.155258_b0410","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.29686","article-title":"Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model","volume":"138","author":"Mathios","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2020.155258_b0415","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood-2017-12-823757","article-title":"First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation","volume":"131","author":"Romee","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b0420","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S1470-2045(18)30148-7","article-title":"ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial","volume":"19","author":"Wrangle","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cyto.2020.155258_b0425","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.imlet.2017.08.010","article-title":"The potential and promise of IL-15 in immuno-oncogenic therapies","volume":"190","author":"Robinson","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2020.155258_b0430","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1084\/jem.20130291","article-title":"Epidermal IL-15Ralpha acts as an endogenous antagonist of psoriasiform inflammation in mouse and man","volume":"210","author":"Bouchaud","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0435","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.4049\/jimmunol.173.3.1681","article-title":"Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist","volume":"173","author":"Mortier","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0440","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2011-10-384362","article-title":"Circulating IL-15 exists as heterodimeric complex with soluble IL-15Ralpha in human and mouse serum","volume":"120","author":"Bergamaschi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b0445","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.4049\/jimmunol.1600219","article-title":"Inflammatory Signals Regulate IL-15 in Response to Lymphodepletion","volume":"196","author":"Anthony","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0450","doi-asserted-by":"crossref","first-page":"e0120274","DOI":"10.1371\/journal.pone.0120274","article-title":"Soluble interleukin-15 complexes are generated in vivo by type I interferon dependent and independent pathways","volume":"10","author":"Anthony","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2020.155258_b0455","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00262-005-0005-x","article-title":"Interferon-alpha\/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha\/beta treatment","volume":"55","author":"Yamaji","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cyto.2020.155258_b0460","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fcimb.2017.00138","article-title":"Ectodomain shedding by ADAM17: its role in neutrophil recruitment and the impairment of this process during sepsis","volume":"7","author":"Mishra","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cyto.2020.155258_b0465","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood-2005-01-0064","article-title":"Membrane-bound and soluble IL-15\/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors","volume":"106","author":"Giron-Michel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b0470","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.celrep.2013.08.021","article-title":"IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditions","volume":"4","author":"Zanoni","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.cyto.2020.155258_b0475","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1073\/pnas.1405514111","article-title":"IL-15.IL-15Ralpha complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells","volume":"111","author":"Tamzalit","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0480","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1073\/pnas.1911678117","article-title":"Trans-endocytosis of intact IL-15Ralpha-IL-15 complex from presenting cells into NK cells favors signaling for proliferation","volume":"117","author":"Anton","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0485","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1200\/JCO.2014.57.3329","article-title":"Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer","volume":"33","author":"Conlon","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2020.155258_b0490","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1182\/blood-2010-03-275438","article-title":"Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates","volume":"116","author":"Lugli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b0495","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1182\/blood-2011-09-377804","article-title":"IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood","volume":"118","author":"Sneller","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b0500","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1182\/blood-2010-10-311456","article-title":"Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques","volume":"117","author":"Waldmann","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b0505","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96219","article-title":"Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect","volume":"3","author":"Felices","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.cyto.2020.155258_b0510","doi-asserted-by":"crossref","first-page":"E10915","DOI":"10.1073\/pnas.1811615115","article-title":"IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0515","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.4049\/jimmunol.1700046","article-title":"Cutting edge: differential fine-tuning of IL-2- and IL-15-dependent functions by targeting their common IL-2\/15Rbeta\/gammac receptor","volume":"198","author":"Meghnem","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0520","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.4049\/jimmunol.171.10.5423","article-title":"Autocrine\/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection","volume":"171","author":"Jinushi","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0525","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1128\/JVI.74.16.7338-7348.2000","article-title":"Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region","volume":"74","author":"Azimi","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2020.155258_b0530","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/10799900260100132","article-title":"Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines","volume":"22","author":"Gary-Gouy","year":"2002","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cyto.2020.155258_b0535","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4049\/jimmunol.167.3.1179","article-title":"IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation","volume":"167","author":"Mattei","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0540","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.4049\/jimmunol.1101883","article-title":"IL-15 can signal via IL-15Ralpha, JNK, and NF-kappaB to drive RANTES production by myeloid cells","volume":"188","author":"Chenoweth","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0545","article-title":"IL-15 and GM-CSF stimulated macrophages enhances phagocytic activity in ENU induced leukemic mice","volume":"151894","author":"Singha","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.cyto.2020.155258_b0550","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/icb.2014.103","article-title":"STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells","volume":"93","author":"Okada","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cyto.2020.155258_b0555","doi-asserted-by":"crossref","first-page":"e51851","DOI":"10.1371\/journal.pone.0051851","article-title":"Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential","volume":"7","author":"Anguille","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2020.155258_b0560","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.yexcr.2014.08.012","article-title":"Downregulation of endogenous STAT3 augments tumoricidal activity of interleukin 15 activated dendritic cell against lymphoma and leukemia via TRAIL","volume":"327","author":"Hira","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"Suppl 3","key":"10.1016\/j.cyto.2020.155258_b0565","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.cyto.2020.155258_b0570","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/art.1780370601","article-title":"Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis","volume":"37","author":"Zvaifler","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2020.155258_b0575","first-page":"644","article-title":"Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta","volume":"23","author":"Ainola","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cyto.2020.155258_b0580","first-page":"845","article-title":"Hypothesis: in vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus","volume":"10","author":"Hamilton","year":"1983","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2020.155258_b0585","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.2010.138693","article-title":"Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction","volume":"70","author":"Aletaha","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2020.155258_b0590","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/eji.200737229","article-title":"IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17","volume":"37","author":"Yoshihara","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0595","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10067-005-0106-0","article-title":"Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis","volume":"25","author":"Petrovic-Rackov","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cyto.2020.155258_b0600","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm0296-175","article-title":"The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis","volume":"2","author":"McInnes","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0605","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1136\/annrheumdis-2011-200724","article-title":"Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study","volume":"71","author":"Knevel","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2020.155258_b0610","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2020.155258_b0615","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/1529-0131(199907)42:7<1508::AID-ANR26>3.0.CO;2-L","article-title":"Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"42","author":"Harada","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2020.155258_b0620","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI1986","article-title":"Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo","volume":"101","author":"Oppenheimer-Marks","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2020.155258_b0625","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1172\/JCI72039","article-title":"IL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking","volume":"124","author":"Nolz","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2020.155258_b0630","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-3083.2008.02118.x","article-title":"Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis","volume":"68","author":"Andersson","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0635","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4049\/jimmunol.173.2.1463","article-title":"IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate","volume":"173","author":"Miranda-Carus","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0640","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2567.2008.02878.x","article-title":"Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis?","volume":"126","author":"Ruckert","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2020.155258_b0645","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.1201620","article-title":"IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens","volume":"190","author":"Deshpande","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0650","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2020.155258_b0655","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/db09-1620","article-title":"Predicting adult-onset autoimmune diabetes: clarity from complexity","volume":"59","author":"Leslie","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2020.155258_b0660","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra0808284","article-title":"Genetics of type 1A diabetes","volume":"360","author":"Concannon","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0665","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrg3069","article-title":"Understanding type 1 diabetes through genetics: advances and prospects","volume":"12","author":"Polychronakos","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cyto.2020.155258_b0670","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diabres.2005.02.007","article-title":"IL-15 is elevated in serum patients with type 1 diabetes mellitus","volume":"69","author":"Kuczynski","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cyto.2020.155258_b0675","doi-asserted-by":"crossref","first-page":"e0146649","DOI":"10.1371\/journal.pone.0146649","article-title":"Serum cytokines as biomarkers in islet cell transplantation for type 1 diabetes","volume":"11","author":"van der Torren","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2020.155258_b0680","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2020.155258_b0685","doi-asserted-by":"crossref","first-page":"13074","DOI":"10.1073\/pnas.0705863104","article-title":"Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts","volume":"104","author":"Koulmanda","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0690","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.160.12.5742","article-title":"Targeting the IL-15 receptor with an antagonist IL-15 mutant\/Fc gamma2a protein blocks delayed-type hypersensitivity","volume":"160","author":"Kim","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0695","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol."},{"issue":"67","key":"10.1016\/j.cyto.2020.155258_b0700","article-title":"Novel roles for IL-15 in T cell survival","volume":"2","author":"Brincks","year":"2010","journal-title":"F1000 Biol Rep"},{"key":"10.1016\/j.cyto.2020.155258_b0705","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.4049\/jimmunol.171.7.3878","article-title":"Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28\/CD154-dependent and -independent mechanisms","volume":"171","author":"Demirci","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0710","doi-asserted-by":"crossref","first-page":"e2435","DOI":"10.1371\/journal.pone.0002435","article-title":"Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation","volume":"3","author":"Huurman","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2020.155258_b0715","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaut.2011.05.012","article-title":"Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers","volume":"37","author":"Unger","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2020.155258_b0720","first-page":"1806","article-title":"Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells","volume":"118","author":"Monti","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2020.155258_b0725","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.4049\/jimmunol.1001221","article-title":"Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes","volume":"186","author":"Ramanathan","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0730","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/icb.2015.78","article-title":"Depletion of IL-2 receptor beta-positive cells protects from diabetes in non-obese diabetic mice","volume":"94","author":"Brauner","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cyto.2020.155258_b0735","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1312911110","article-title":"Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Ralpha","author":"Chen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cyto.2020.155258_b0740","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96600","article-title":"CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms","volume":"3","author":"Yuan","year":"2018","journal-title":"JCI Insight"},{"issue":"161","key":"10.1016\/j.cyto.2020.155258_b0745","first-page":"162","article-title":"Co-expression of IL-15 and IL-15R\u03b1 on pancreatic \u03b2 islet cells induced insulin dependent diabetes mellitus in mice (161.2)","volume":"188","author":"Chen","year":"2012","journal-title":"J. Immunol."},{"issue":"80","key":"10.1016\/j.cyto.2020.155258_b0750","first-page":"16","article-title":"Restoration of immune tolerance in type 1 diabetes by modulating interleukin-2 receptor signaling","volume":"198","author":"Yuan","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0755","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2002-19959","article-title":"Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15","volume":"34","author":"Rothe","year":"2002","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cyto.2020.155258_b0760","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00125-002-1017-0","article-title":"IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice","volume":"46","author":"Cardozo","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.cyto.2020.155258_b0765","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/cmi.2015.102","article-title":"Trans-presentation of interleukin-15 by interleukin-15 receptor alpha is dispensable for the pathogenesis of autoimmune type 1 diabetes","volume":"14","author":"Bobbala","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0770","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrgastro.2017.110","article-title":"The IBD interactome: an integrated view of aetiology, pathogenesis and therapy","volume":"14","author":"de Souza","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2020.155258_b0775","doi-asserted-by":"crossref","first-page":"493012","DOI":"10.1155\/2015\/493012","article-title":"Inflammatory bowel disease: an overview of immune mechanisms and biological treatments","volume":"2015","author":"de Mattos","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2020.155258_b0780","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0785","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","article-title":"Inflammatory bowel disease","volume":"28","author":"Kaser","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0790","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/apt.12284","article-title":"Review article: the role of anti-TNF in the management of ulcerative colitis \u2013 past, present and future","volume":"37","author":"Danese","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.cyto.2020.155258_b0795","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrgastro.2013.118","article-title":"IBD: Antibodies to anti-TNF therapy\u2013consequences for IBD management","volume":"10","author":"van Deen","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2020.155258_b0800","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5009\/gnl14226","article-title":"Current and emerging biologics for ulcerative colitis","volume":"9","author":"Park","year":"2015","journal-title":"Gut Liver"},{"key":"10.1016\/j.cyto.2020.155258_b0805","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082244","article-title":"Anti-TNF therapy in Crohn's disease","volume":"19","author":"Adegbola","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2020.155258_b0810","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group","volume":"337","author":"Targan","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0815","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.40.4.443","article-title":"Tumour necrosis factor and Crohn's disease","volume":"40","author":"Van Deventer","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2020.155258_b0820","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn's disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0825","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ibd\/izy302","article-title":"Ustekinumab is effective for the treatment of Crohn's disease of the pouch in a multicenter cohort","volume":"25","author":"Weaver","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cyto.2020.155258_b0830","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as induction and maintenance therapy for ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0835","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMe1910742","article-title":"Biologics beyond Anti-TNF agents for ulcerative colitis \u2013 efficacy, safety, and cost?","volume":"381","author":"Farrell","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0840","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","article-title":"IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting","volume":"16","author":"Moschen","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2020.155258_b0845","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0850","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2020.155258_b0855","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.14309\/crj.2018.56","article-title":"Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion","volume":"5","author":"Wang","year":"2018","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.cyto.2020.155258_b0860","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","article-title":"IL-15: a central regulator of celiac disease immunopathology","volume":"260","author":"Abadie","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2020.155258_b0865","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/gut.2005.076000","article-title":"Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice","volume":"55","author":"Yoshihara","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2020.155258_b0870","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2012.05.013","article-title":"Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes","volume":"37","author":"Schulthess","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0875","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0880","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.4049\/jimmunol.164.7.3608","article-title":"IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production","volume":"164","author":"Liu","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0885","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0016-5085(98)70430-5","article-title":"Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease","volume":"114","author":"Sakai","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2020.155258_b0890","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00535-004-1510-y","article-title":"Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease","volume":"40","author":"Nishiwaki","year":"2005","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cyto.2020.155258_b0895","doi-asserted-by":"crossref","first-page":"580450","DOI":"10.1155\/2009\/580450","article-title":"High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD","volume":"2009","author":"Leon","year":"2009","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2020.155258_b0900","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1053\/j.gastro.2010.02.044","article-title":"Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease","volume":"138","author":"Bouchaud","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2020.155258_b0905","doi-asserted-by":"crossref","first-page":"e0182313","DOI":"10.1371\/journal.pone.0182313","article-title":"Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease","volume":"12","author":"Vitale","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2020.155258_b0910","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ismej.2016.114","article-title":"Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis","volume":"11","author":"Meisel","year":"2017","journal-title":"ISME J."},{"key":"10.1016\/j.cyto.2020.155258_b0915","article-title":"Enteroids derived from inflammatory bowel disease patients display dysregulated endoplasmic reticulum stress pathways, leading to differential inflammatory responses and dendritic cell maturation","author":"Rees","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.cyto.2020.155258_b0920","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/imr.12644","article-title":"The role of cytokines in T-cell memory in health and disease","volume":"283","author":"Raeber","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2020.155258_b0925","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/jid.2008.308","article-title":"Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association","volume":"129","author":"Duffin","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2020.155258_b0930","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1038\/jid.2008.148","article-title":"No association between polymorphisms in the interleukin-15 gene and early-onset psoriasis in a UK cohort suggests heterogeneity for this susceptibility locus identified in Chinese psoriasis patients","volume":"128","author":"Smith","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2020.155258_b0935","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jdermsci.2008.02.010","article-title":"Role of the interleukin 15 96516A>T and IL15 96330C>A gene polymorphisms in Caucasian patients with chronic plaque psoriasis","volume":"51","author":"Weger","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.cyto.2020.155258_b0940","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha","volume":"199","author":"Boyman","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155258_b0945","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI200318986","article-title":"Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model","volume":"112","author":"Villadsen","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2020.155258_b0950","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/sj.jid.5700855","article-title":"IL-15 and psoriasis: another genetic link to Th17?","volume":"127","author":"Elder","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2020.155258_b0955","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155258_b0960","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2040622317738910","article-title":"Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis","volume":"9","author":"Frieder","year":"2018","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.cyto.2020.155258_b0965","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5152\/eurjrheum.2017.17037","article-title":"Targeting IL-17 in psoriatic arthritis","volume":"4","author":"Wang","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.cyto.2020.155258_b0970","doi-asserted-by":"crossref","first-page":"539683","DOI":"10.1155\/2012\/539683","article-title":"The Th17\/IL-23 axis and natural immunity in psoriatic arthritis","volume":"2012","author":"Maeda","year":"2012","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.cyto.2020.155258_b0975","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.4049\/jimmunol.173.9.5818","article-title":"Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15\/Fc protein prevents disease development and progression in murine collagen-induced arthritis","volume":"173","author":"Ferrari-Lacraz","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0980","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.4049\/jimmunol.160.11.5654","article-title":"Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology","volume":"160","author":"Ruchatz","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0985","doi-asserted-by":"crossref","first-page":"e78619","DOI":"10.1371\/journal.pone.0078619","article-title":"Systemic delivery of small interfering RNA targeting the interleukin-2\/15 receptor beta chain prevents disease progression in experimental arthritis","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2020.155258_b0990","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.molimm.2010.01.023","article-title":"Interleukin-15 receptor-directed immunotoxins atteunuate disease severity in rat adjuvant arthritis","volume":"47","author":"Wang","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b0995","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1741-7015-11-88","article-title":"Biologic therapy for autoimmune diseases: an update","volume":"11","author":"Rosman","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.cyto.2020.155258_b1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-015-0092-3","article-title":"A review of biologic therapies targeting IL-23 and IL-17 for use in moderate-to-severe plaque psoriasis","volume":"6","author":"Campa","year":"2016","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"10.1016\/j.cyto.2020.155258_b1005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/ar1871","article-title":"Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor","volume":"8","author":"Ernestam","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2020.155258_b1010","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.21249","article-title":"Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study","volume":"52","author":"Baslund","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2020.155258_b1015","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/annrheumdis-2019-215764","article-title":"Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response","volume":"78","author":"Fleischmann","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2020.155258_b1020","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/rheumatology\/key225","article-title":"Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis","volume":"58","author":"Taylor","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2020.155258_b1025","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18688.1","article-title":"Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies","volume":"8","author":"Senolt","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.cyto.2020.155258_b1030","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study","volume":"4","author":"Lahdeaho","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2020.155258_b1035","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2020.155258_b1040","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.4049\/jimmunol.1301000","article-title":"Homeostasis of human NK cells is not IL-15 dependent","volume":"191","author":"Lebrec","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b1045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/19420862.2017.1332553","article-title":"Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis","volume":"9","author":"Vicari","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.cyto.2020.155258_b1050","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3389\/fimmu.2018.01603","article-title":"Beneficial effects of human anti-interleukin-15 antibody in gluten-sensitive rhesus macaques with celiac disease","volume":"9","author":"Sestak","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b1055","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s10875-011-9586-7","article-title":"Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease","volume":"31","author":"Yokoyama","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b1060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cyto.2020.155258_b1065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood-2012-08-450585","article-title":"Phase 1 trial of IL-15 trans presentation blockade using humanized Mikbeta1 mAb in patients with T-cell large granular lymphocytic leukemia","volume":"121","author":"Waldmann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155258_b1070","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/acn3.50820","article-title":"Clinical trial of a humanized anti-IL-2\/IL-15 receptor beta chain in HAM\/TSP","volume":"6","author":"Enose-Akahata","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.cyto.2020.155258_b1075","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41375-018-0290-y","article-title":"IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective gamma-chain cytokines, decreases leukemic T-cell viability","volume":"33","author":"Wang","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2020.155258_b1080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12865-016-0168-6","article-title":"Active immunization with human interleukin-15 induces neutralizing antibodies in non-human primates","volume":"17","author":"Rodriguez-Alvarez","year":"2016","journal-title":"BMC Immunol."},{"key":"10.1016\/j.cyto.2020.155258_b1085","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10875-012-9849-y","article-title":"Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease","volume":"33","author":"Yokoyama","year":"2013","journal-title":"J. Clin. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662030274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662030274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:59:49Z","timestamp":1760907589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662030274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":217,"alternative-id":["S104346662030274X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155258","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-15 in autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155258"}}